Clinical Trial Evaluating ITI-007 as an Adjunctive Therapy to Lithium or Valproate for the Treatment of Bipolar Depression
Status:
Completed
Trial end date:
2020-07-02
Target enrollment:
Participant gender:
Summary
The study will evaluate the efficacy and safety of ITI-007 adjunctive to lithium or valproate
in a randomized, double-blind, parallel-group, placebo-controlled, multi-center study in
patients diagnosed with Bipolar I or Bipolar II disorder having a major depressive episode.